Sino Biological Unveils Advanced AI-Trusted Protein Collections to Enhance Discovery Process

Sino Biological Introduces Innovative AI-Driven Protein Collections



In a bold move to accelerate the promise of artificial intelligence in biotechnology, Sino Biological, a trailblazing firm in recombinant proteins, recently unveiled two carefully curated collections aimed to enrich AI-driven discovery in therapeutic and diagnostic applications. With the increasing reliance on AI to expedite the development of recombinant proteins and antibodies, the quality and characterization of the available target proteins are paramount. In response to this demand, the company introduced AI-Trusted Proteins and AI-Qualified Proteins, designed to bolster research needs and effectively evaluate AI-generated molecules.

AI-Trusted Proteins: Proven and Reliable


The AI-Trusted Proteins collection is robust, encompassing over 600 targets and more than 960 individual proteins. These proteins have successfully been utilized in validation projects by various AI-focused companies, with many having been featured in peer-reviewed research. Each protein in this collection comes with a comprehensive set of characterization data that may include results from Surface Plasmon Resonance (SPR), Bio-Layer Interferometry (BLI), Enzyme-Linked Immunosorbent Assays (ELISA), cell-based activity assays, and advanced separation techniques like Size Exclusion High-Performance Liquid Chromatography (SEC-HPLC) and SEC-MALS analyses. This rigorous backing ensures that researchers can confidently utilize these proteins in their AI validation efforts.

AI-Qualified Proteins: Thoroughly Characterized and Versatile


On the other hand, the AI-Qualified Proteins collection extends this commitment to excellence by focusing on experimentally characterized target binding activities. This collection boasts over 680 targets and 1,700 individual proteins, significantly broadening the scope for researchers. Each protein has been rigorously tested for binding and activity, complete with SPR/BLI validation data and specialized formats like biotinylated proteins to cater specifically to AI-focused research applications. The depth of characterization included in this collection provides scientists with the reliable information they need to evaluate the effectiveness of AI-designed molecules effectively.

Supporting Infrastructure: The 4S System


To guarantee reliable access to these extensive resources, Sino Biological's operations are bolstered by their innovative 4S System—Scale, Scope, Speed, and Supply. This system not only promises an impressive inventory of over 11,000 recombinant target proteins but also ensures diverse protein formats and a dependable long-term supply chain to sustain various AI-driven research initiatives.

In addition to these collections, Sino Biological has also created a therapeutic target directory. This directory covers 12 therapeutic areas and more than 100 diseases, allowing researchers to easily navigate relevant targets based on specific therapeutic interests. By connecting researchers with a wealth of target options, this tool enhances the efficiency and relevance of their studies, ultimately driving successful discovery outcomes.

The 4RISE™ Initiative: Integrating AI and Lab Validation


Furthermore, the launch of 4RISE™, an advanced AI Lab Validation Solution, underscores the company's commitment to integrating AI into the research landscape. This initiative combines the AI-focused target protein library with features for rapid protein expression, binding and affinity characterization, developability assessments, and functional validations. Built around four core principles — Rapid, In-Depth, Seamless, and Empirical — 4RISE™ delivers comprehensive wet-lab support to facilitate the transition of AI-designed molecules from theoretical models to practical experimentation.

According to Dr. Rob Burgess, Chief Business Officer at Sino Biological, “AI-driven discovery depends on reliable experimental resources to evaluate designed molecules and guide subsequent research decisions. By offering a combination of AI-Trusted and AI-Qualified proteins, along with our comprehensive 4S System, we aim to empower researchers with the best resources available to support their endeavors in therapeutic and antibody development.”

With these innovative offerings, Sino Biological is poised to lead the way in AI-driven biological discovery, ensuring that researchers have access to the most reliable and relevant resources for their cutting-edge projects.

Topics Other)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.